FKBP9

Across TCGA cell cohorts, FKBP9 mutation is significantly associated with the drug of many other genes, with 21 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible FKBP9-associated genes across cancer lineages are GSK2276186C, GSK1070916, and Masitinib. Each is linked with FKBP9 in more than 1 cancer types. Because this analysis shows association rather than direction, both FKBP9-to-partner and partner-to-FKBP9 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, GSK2276186C grouped by FKBP9-low versus FKBP9-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (FKBP9→partner) and Y-score (partner→FKBP9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LARGE_INTESTINE	GSK2276186C →	+0.460	+2.649	.048	.046	3	1
LARGE_INTESTINE	GSK1070916 →	+0.763	+2.655	.009	.044	3	1
LARGE_INTESTINE	Masitinib →	+0.451	+2.652	.036	.045	3	1
LARGE_INTESTINE	Tivozanib →	+0.252	+2.786	.025	.037	3	1
LARGE_INTESTINE	PRT062607 →	+0.576	+2.769	.022	.040	2	1
LARGE_INTESTINE	GSK2110183B →	+0.676	+2.649	.026	.046	2	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 21 associations by consensus.

GSK2276186C by FKBP9 expression — LARGE_INTESTINE

Explore this box plot interactively →